ArticleJournal of oncology2022

Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors.

Jianzheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.